Reporte zur Charge 9399021A

Symptomtext

She had burning in nose.; She could taste chemical in her mouth.; Within 42 to 78 hours after 1st and 2nd dose, she had constant menstrual bleeding that heavy with large blood clots/She is still bleeding heavily; She had mild fatigue on same day and following day after 1st dose and 2nd dose.; She started with immediate burning and pain at injection site.; This spontaneous case was reported by a consumer and describes the occurrence of NASAL DISCOMFORT (She had burning in nose.), DYSGEUSIA (She could taste chemical in her mouth.), HEAVY MENSTRUAL BLEEDING (Within 42 to 78 hours after 1st and 2nd dose, she had constant menstrual bleeding that heavy with large blood clots/She is still bleeding heavily), FATIGUE (She had mild fatigue on same day and following day after 1st dose and 2nd dose.) and VACCINATION SITE PAIN (She started with immediate burning and pain at injection site.) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 9399021A) for COVID-19 vaccination. Concomitant products included VITAMINS NOS and IRON for an unknown indication. On 26-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASAL DISCOMFORT (She had burning in nose.), DYSGEUSIA (She could taste chemical in her mouth.), HEAVY MENSTRUAL BLEEDING (Within 42 to 78 hours after 1st and 2nd dose, she had constant menstrual bleeding that heavy with large blood clots/She is still bleeding heavily), FATIGUE (She had mild fatigue on same day and following day after 1st dose and 2nd dose.) and VACCINATION SITE PAIN (She started with immediate burning and pain at injection site.). At the time of the report, NASAL DISCOMFORT (She had burning in nose.), DYSGEUSIA (She could taste chemical in her mouth.), HEAVY MENSTRUAL BLEEDING (Within 42 to 78 hours after 1st and 2nd dose, she had constant menstrual bleeding that heavy with large blood clots/She is still bleeding heavily), FATIGUE (She had mild fatigue on same day and following day after 1st dose and 2nd dose.) and VACCINATION SITE PAIN (She started with immediate burning and pain at injection site.) outcome was unknown. Treatment information was included birth control. This case was linked to MOD-2021-313046.